Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-071417
Filing Date
2021-05-25
Accepted
2021-05-24 20:00:10
Documents
4
Period of Report
2021-06-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212691d1_def14a.htm DEF 14A 479474
2 GRAPHIC tm212691d1_def14aimg0010.jpg GRAPHIC 43193
3 GRAPHIC tm212691d1_card.jpg GRAPHIC 145310
4 GRAPHIC tm212691d1_card2.jpg GRAPHIC 132164
  Complete submission text file 0001104659-21-071417.txt   922833
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32295 | Film No.: 21956962
SIC: 2836 Biological Products, (No Diagnostic Substances)